Literature DB >> 17683918

Dopamine D2/D3 receptor binding in the anterior cingulate cortex and executive functioning.

Ville Lumme1, Sargo Aalto, Tuula Ilonen, Kjell Någren, Jarmo Hietala.   

Abstract

The objective was to investigate the association between extrastriatal dopamine D(2)/D(3) receptor binding and performance on the Wisconsin Card Sorting Test (WCST), a measure of executive functioning. Thirty-two healthy volunteers performed the WCST and underwent positron emission tomography and a high-affinity D(2)/D(3) receptor tracer, [(11)C]FLB 457. All WCST error parameters, in particular nonperseverative errors, correlated positively with [(11)C]FLB 457 binding in the cognitive division of the right anterior cingulate cortex. An independent voxel-based receptor parametric mapping analysis confirmed these findings. The results indicate that executive functioning in healthy volunteers is modulated by D(2)/D(3) receptors in the anterior cingulate cortex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683918     DOI: 10.1016/j.pscychresns.2006.12.012

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  17 in total

1.  Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study.

Authors:  Ji Hyun Ko; Alain Ptito; Oury Monchi; Sang Soo Cho; Thilo Van Eimeren; Giovanna Pellecchia; Benedicte Ballanger; Pablo Rusjan; Sylvain Houle; Antonio P Strafella
Journal:  Neuroimage       Date:  2009-03-03       Impact factor: 6.556

2.  Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study.

Authors:  Naren Rao; Georg Northoff; Abanti Tagore; Pablo Rusjan; Miran Kenk; Alan Wilson; Sylvain Houle; Antonio Strafella; Gary Remington; Romina Mizrahi
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

3.  Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease.

Authors:  Ji Hyun Ko; Francesca Antonelli; Oury Monchi; Nicola Ray; Pablo Rusjan; Sylvain Houle; Anthony E Lang; Leigh Christopher; Antonio P Strafella
Journal:  Hum Brain Mapp       Date:  2012-02-14       Impact factor: 5.038

4.  The C957T polymorphism in the dopamine receptor D₂ gene modulates domain-general category learning.

Authors:  Zilong Xie; W Todd Maddox; John E McGeary; Bharath Chandrasekaran
Journal:  J Neurophysiol       Date:  2015-03-11       Impact factor: 2.714

Review 5.  Caffeine as an attention enhancer: reviewing existing assumptions.

Authors:  Suzanne J L Einöther; Timo Giesbrecht
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

6.  Cariprazine, a dopamine D(3)-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse.

Authors:  Ross Zimnisky; Gloria Chang; István Gyertyán; Béla Kiss; Nika Adham; Claudia Schmauss
Journal:  Psychopharmacology (Berl)       Date:  2012-10-19       Impact factor: 4.530

Review 7.  Executive function, neural circuitry, and genetic mechanisms in schizophrenia.

Authors:  Daniel Paul Eisenberg; Karen Faith Berman
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 8.  The neural circuitry of executive functions in healthy subjects and Parkinson's disease.

Authors:  Sandra E Leh; Michael Petrides; Antonio P Strafella
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Establishing norms for error-related brain activity during the arrow Flanker task among young adults.

Authors:  Michael J Imburgio; Iulia Banica; Kaylin E Hill; Anna Weinberg; Dan Foti; Annmarie MacNamara
Journal:  Neuroimage       Date:  2020-03-03       Impact factor: 6.556

10.  rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex.

Authors:  Sang Soo Cho; Antonio P Strafella
Journal:  PLoS One       Date:  2009-08-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.